Rheos Capital Works’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50,000
Closed -$9.75M 78
2025
Q4
$9.75M Buy
+50,000
New +$11.9M 0.62% 50
2023
Q4
Sell
-333,000
Closed -$35.3M 114
2023
Q3
$35.3M Sell
333,000
-139,000
-29% -$16.1M 2.12% 10
2023
Q2
$56.2M Hold
472,000
3.02% 4
2023
Q1
$43.9M Buy
472,000
+265,000
+128% +$23.2M 2.44% 9
2022
Q4
$16.9M Sell
207,000
-150,000
-42% -$11.4M 1.02% 31
2022
Q3
$21.8M Buy
357,000
+50,000
+16% +$3.66M 1.47% 14
2022
Q2
$21.4M Hold
307,000
1.61% 10
2022
Q1
$25.4M Buy
+307,000
New +$24.9M 1.22% 19

Other funds holding ORCL

Rheos Capital Works's ORCL Position: Q1 2026 in Review

Rheos Capital Works sold out of Oracle (ORCL) in Q1 2026, closing a stake of 50,000 shares — an estimated $9.75M sold.

Rheos Capital Works first reported a position in ORCL in Q1 2022 and held it in 8 quarters. The position peaked at $56.2M in Q2 2023. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Rheos Capital Works reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Rheos Capital Works sold 50,000 Oracle shares in Q1 2026, an estimated $9.75M.
  • Rheos Capital Works first reported a position in Oracle in Q1 2022 and held it in 8 quarters.
  • Rheos Capital Works's Oracle position peaked at $56.2M in Q2 2023.
  • 3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Rheos Capital Works's 13F filing for Q1 2026, filed 8 May 2026.